A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558
Adnexal Diseases, Endocrine Gland Neoplasms
Miami Beach, Florida, United States
View Trial DetailsNCT Number: NCT02803970
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
Interested in participating?
Request InfoFemale
Observational
Samsung Changwon Hospital, Changwon, South Korea
The researchers retrospectively collected data on Korean patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. And the researchers prospectively will collect data on all Korean patients with BOTs at institutions where placed in the Republic of Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database. The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care. Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 100 months
Contact information is provided by the study sponsor or research team.
Kangbuk Samsung Hospital
Other
Establishing the Registry of Korean Patients With Borderline Ovarian Tumors
Acronym: KOBOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07318558
Adnexal Diseases, Endocrine Gland Neoplasms
Miami Beach, Florida, United States
View Trial DetailsNCT07075939
Adnexal Diseases, Advanced Ovarian Cancer
Carpi, Modena, Italy
View Trial DetailsNCT07286266
Adnexal Diseases, Endocrine Gland Neoplasms
Randwick, New South Wales, Australia
View Trial DetailsNCT07213791
Adenocarcinoma, Adnexal Diseases
Newport Beach, California, United States
View Trial Details